Computer-assisted quantification of plus disease after treatment of retinopathy of prematurity with intravitreal bevacizumab
Publication
, Journal Article
Gertsch, KR; Wallace, D; Ulrich, JN; Enyedi, L; Cabrera, M
Published in: Journal of American Association for Pediatric Ophthalmology and Strabismus
February 2013
Duke Scholars
Published In
Journal of American Association for Pediatric Ophthalmology and Strabismus
DOI
ISSN
1091-8531
Publication Date
February 2013
Volume
17
Issue
1
Start / End Page
e15 / e16
Publisher
Elsevier BV
Related Subject Headings
- Ophthalmology & Optometry
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gertsch, K. R., Wallace, D., Ulrich, J. N., Enyedi, L., & Cabrera, M. (2013). Computer-assisted quantification of plus disease after treatment of retinopathy of prematurity with intravitreal bevacizumab. Journal of American Association for Pediatric Ophthalmology and Strabismus, 17(1), e15–e16. https://doi.org/10.1016/j.jaapos.2012.12.055
Gertsch, Kevin R., David Wallace, J Niklas Ulrich, Laura Enyedi, and Michelle Cabrera. “Computer-assisted quantification of plus disease after treatment of retinopathy of prematurity with intravitreal bevacizumab.” Journal of American Association for Pediatric Ophthalmology and Strabismus 17, no. 1 (February 2013): e15–16. https://doi.org/10.1016/j.jaapos.2012.12.055.
Gertsch KR, Wallace D, Ulrich JN, Enyedi L, Cabrera M. Computer-assisted quantification of plus disease after treatment of retinopathy of prematurity with intravitreal bevacizumab. Journal of American Association for Pediatric Ophthalmology and Strabismus. 2013 Feb;17(1):e15–6.
Gertsch, Kevin R., et al. “Computer-assisted quantification of plus disease after treatment of retinopathy of prematurity with intravitreal bevacizumab.” Journal of American Association for Pediatric Ophthalmology and Strabismus, vol. 17, no. 1, Elsevier BV, Feb. 2013, pp. e15–16. Crossref, doi:10.1016/j.jaapos.2012.12.055.
Gertsch KR, Wallace D, Ulrich JN, Enyedi L, Cabrera M. Computer-assisted quantification of plus disease after treatment of retinopathy of prematurity with intravitreal bevacizumab. Journal of American Association for Pediatric Ophthalmology and Strabismus. Elsevier BV; 2013 Feb;17(1):e15–e16.
Published In
Journal of American Association for Pediatric Ophthalmology and Strabismus
DOI
ISSN
1091-8531
Publication Date
February 2013
Volume
17
Issue
1
Start / End Page
e15 / e16
Publisher
Elsevier BV
Related Subject Headings
- Ophthalmology & Optometry
- 1103 Clinical Sciences